Cite
HARVARD Citation
Zhang, Q. et al. (n.d.). 153P Neoadjuvant therapy with tislelizumab plus chemotherapy followed by concurrent chemoradiotherapy in patients with stage IVa nasopharyngeal carcinoma: A single-arm, phase II trial. Immuno-oncology technology. p. . [Online].